Worth reading
38Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
12200
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
Number of shares delivered during the month: 12,200 shares (new shares: 0 shares; transferred treasury shares: 12,200 shares)
発行済株式総数
0.7% (12,200 shares delivered, including all series / 1,789,487 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices in July 2026: ¥1,525, ¥1,607, ¥1,629, ¥1,668, ¥1,700, ¥1,746, ¥1,755, ¥1,787, ¥1,827 and ¥1,848. Details of the adjustment clause and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 3,759 rights (122 rights, or 3.2% of the total issued); unexercised as of the end of the month preceding the subject month: 3,637 rights; unexercised as of the end of the subject month: 3,515 rights
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Timing 10 March 2025 / Type Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 12,200 shares (new shares: 0 shares; transferred treasury shares: 12,200 shares) |
| Dilution Rate | 0.7% (12,200 shares delivered, including all series / 1,789,487 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 1,789,487 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | Exercise prices in July 2026: ¥1,525, ¥1,607, ¥1,629, ¥1,668, ¥1,700, ¥1,746, ¥1,755, ¥1,787, ¥1,827 and ¥1,848. Details of the adjustment clause and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 3,759 rights (122 rights, or 3.2% of the total issued); unexercised as of the end of the month preceding the subject month: 3,637 rights; unexercised as of the end of the subject month: 3,515 rights |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Timing 10 March 2025 / Type Second Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in July 2026 of the 2nd Series Stock Acquisition Rights issued through a third-party allotment on 10 March 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.